Blog Profile / PharmaGossip

Filed Under:Medical / Pharmaceutical
Posts on Regator:3975
Posts / Week:10.7
Archived Since:March 4, 2008

Blog Post Archive


WHO calls for increased transparency in medical research Note for the media 14 April 2015 14 APRIL | 2015 GENEVA - WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. Show More Summary

Read it and weep - then get angry!

The Deadly Corruption of Clinical Trials Update (4/3/2015): After nearly 11 years of obfuscation and denial surrounding the tragic death of Dan Markingson, the University of Minnesota has suspended enrollment in psychiatric drug trials. Show More Summary

Tales from the PMCPA contd. - The case of the beer drinking, lederhosen wearing, presenter

?A pulmonologist working in Germany, complained about a scientific symposium organised by Boehringer Ingelheim at the European Respiratory Society (ERS) Congress held in Munich.The symposium was part of the industry sponsored sessions. Show More Summary

Mother brought to tears hearing Johnson & Johnson's Risperdal tactics

David Sell Posted: Friday, January 30, 2015, 8:05 AM Benita Pledger dabbed at her tears as she sat in a wooden chair outside a court room in Philadelphia's City Hall early Thursday evening. "I'm just having a hard time right now," she...Show More Summary

Maurice Saatchi's Medical Innovation Bill is more likely to make its proposer money than it is to help anyone who's sick.

Maurice Saatchi, his Medical Innovation Bill, and the booming ‘orphan drugs’ market Wikimedia Maurice Saatchi has had a great deal of media attention lately. This has focused for the most part on his Medical Innovation Bill (also known...Show More Summary

NICE - what's hot in 2015

The Medicines and Prescribing Centre at NICE has published the 2015 update to Key therapeutic topics - Medicines management options for local implementation (PDF).This publication summarises key therapeutic areas where there are potential...Show More Summary

Daiichi Sankyo Inc. Agrees to Pay $39 Million to Settle Kickback Allegations Under the False Claims Act

Department of JusticeOffice of Public AffairsFOR IMMEDIATE RELEASEFriday, January 9, 2015Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, has agreed to pay the United States and state Medicaid...Show More Summary

Copyright © 2015 Regator, LLC